TITLE

Random effects and latent processes approaches for analyzing binary longitudinal data with missingness: a comparison of approaches using opiate clinical trial data

AUTHOR(S)
Albert, Paul S.; Follmann, Dean A.
PUB. DATE
October 2007
SOURCE
Statistical Methods in Medical Research;Oct2007, Vol. 16 Issue 5, p417
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The analysis of longitudinal data with non-ignorable missingness remains an active area in biostatistics research. This article discusses various random effects and latent process models which have been proposed for analyzing longitudinal binary data subject to both non-ignorable intermittent missing data and dropout. These models account for non-ignorable missingness by introducing random effects or a latent process which is shared between the response model and the model for the missing-data mechanism. We discuss various random effects and latent processes approaches and compare these approaches with analyses from an opiate clinical trial data set, which had high proportion of intermittent missingness and dropout. We also compare these random effect and latent process approaches with other methods for accounting for non-ignorable missingness using this data set.
ACCESSION #
26663022

 

Related Articles

  • Inconsistent Definitions for Intention-To-Treat in Relation to Missing Outcome Data: Systematic Review of the Methods Literature. Alshurafa, Mohamad; Briel, Matthias; Akl, Elie A.; Haines, Ted; Moayyedi, Paul; Gentles, Stephen J.; Rios, Lorena; Chau Tran; Bhatnagar, Neera; Lamontagne, Francois; Walter, Stephen D.; Guyatt, Gordon H. // PLoS Clinical Trials;Nov2012, Vol. 7 Issue 11, p1 

    Background: Authors of randomized trial reports seem to hold a variety of views regarding the relationship between missing outcome data (MOD) and intention to treat (ITT). The objectives of this study were to systematically investigate how authors of methodology articles define ITT in the...

  • Addressing Missing Data in Clinical Trials. Fleming, Thomas R. // Annals of Internal Medicine;1/18/2011, Vol. 154 Issue 2, p113 

    The reliability and interpretability of results from clinical trials can be substantially reduced by missing data. Frequently used approaches to address these concerns, such as upward adjustments in sample sizes or simplistic methods for handling missing data, including...

  • Missing data and the trouble with LOCF. Streiner, David L. // Evidence Based Mental Health;Feb2008, Vol. 11 Issue 1, p3 

    The article discusses the approach on how to handle a missing data in clinical research, and explores the problems with last observation carried forward (LOCF). The possible reasons for a missing data are presented, as well the methods used to estimate the missing data. The arguments of the...

  • Reporting attrition in randomised controlled trials. Dumville, Jo C.; Torgerson, David; Hewitt, Catherine E. // BMJ: British Medical Journal (International Edition);4/22/2006, Vol. 332 Issue 7547, p969 

    The article discusses the effect of attrition in randomized controlled medical trials. The authors point out that participants in trials are sometimes lost to follow-up, and that such attrition can introduce bias, and prevents a full analysis. They propose that researchers should be more...

  • An exploration of the missing data mechanism in an Internet based smoking cessation trial. Jackson, Dan; Mason, Dan; White, IanR.; Sutton, Stephen // BMC Medical Research Methodology;2012, Vol. 12 Issue 1, p157 

    Background: Missing outcome data are very common in smoking cessation trials. It is often assumed that all such missing data are from participants who have been unsuccessful in giving up smoking ("missing=smoking"). Here we use data from a recent Internet based smoking cessation trial in order...

  • Missing Data. Newgard, Craig D.; Lewis, Roger J. // JAMA: Journal of the American Medical Association;9/1/2015, Vol. 314 Issue 9, p940 

    The article looks at the possible imputation methodologies for handling missing data in a clinical study so as to determine the most valid results and to avoid introducing bias, focusing on an article by George L. Bakris and colleagues in the current issue reporting their randomized clinical...

  • How well is the clinical importance of study results reported? An assessment of randomized controlled trials. Chan, Karen B.Y.; Man-Son-Hing, Malcom; Molnar, Frank J.; Laupacis, Andreas // CMAJ: Canadian Medical Association Journal;10/30/2001, Vol. 165 Issue 9, p1197 

    Background The interpretation of the results of randomized controlled trials (RCTs) has traditionally emphasized statistical significance rather than clinical importance. Our aim was to assess the quality of reporting of factors related to clinical importance in a sample of published RCTs....

  • Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Dunn, Graham; Maracy, Mohammad; Tomenson, Barbara // Statistical Methods in Medical Research;Aug2005, Vol. 14 Issue 4, p369 

    Perfectly implemented randomized clinical trials, particularly of complex interventions, are extremely rare. Almost always they are characterized by imperfect adherence to the randomly allocated treatment and variable amounts of missing outcome data. Here we start by describing a wide variety of...

  • Researchers claim clinical trials are reported with misleading statistics. Mayor, Susan // BMJ: British Medical Journal (International Edition);6/8/2002, Vol. 324 Issue 7350, p1353 

    Addresses claims made by U.S. researchers that most randomized trials of new treatments published in leading medical journals are reported in a potentially misleading manner. Contention that the statistics are designed to make results appear more positive than if other statistical tests were...

  • Handling Missing Data in a Duloxetine Population Pharmacokinetic/Pharmacodynamic Model - Imputation Methods and Selection Models. Yuen, Eunice; Gueorguieva, Ivelina; Aarons, Leon // Pharmaceutical Research;Oct2014, Vol. 31 Issue 10, p2829 

    Purpose: In pharmacokinetic (PK)/pharmacodynamic (PD) modelling and simulations (M&S), omitting dropouts can cause inaccuracies in parameter estimation and clinical trial simulations (CTS). This study examines the impact of different imputation methods for missing data on the interpretation of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics